Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
DNA-damaging molecules in the gut linked to colon cancer
A new Yale study linking a DNA-damaging molecule in the gut to colorectal cancer may give us a way to prevent the deadly disease.
New mRNA vaccine for flu and COVID-19 enters human trials
Pfizer and BioNTech’s new mRNA vaccine designed to protect against COVID-19 and the flu has entered human trials.
New study will put the leading theory about Alzheimer’s to the test
Washington University in St. Louis is embarking on a drug trial that may also put the amyloid hypothesis to its ultimate test.
Organ regeneration could overcome liver failure, without a transplant
Patients wait from 30 days to over five years to receive a liver transplant in the U.S. What if the liver could regenerate itself instead?
“Freakonomics” study offers simple strategy for making tough decisions
People who chose change over inaction, regardless of the decision, self-reported being better off and happier after six months.
AI could help cancer patients avoid a deadly recurrence
A new study found that AI can use a patient’s initial skin cancer growth to predict their risk of melanoma recurrence.
New exercise study could find drugs that mimic working out
MIT and Harvard researchers mapped out many of the cells, genes, and cellular pathways that are modified by exercise or high-fat diet.
7 ways CRISPR is shaping the future of food
Using the powerful gene-editing tool CRISPR, researchers are altering crops and animals to add desirable traits and remove undesirable ones.
Pfizer’s RSV vaccine for pregnant women protects newborns
Pfizer plans to begin the regulatory approval process by the end of the year.
These earbuds can tell if a newborn has hearing problems
A newborn hearing screening device made from off-the-shelf earbuds is as effective as expensive commercial options.
These psychedelic “body snatchers” regenerate their bodies and absorb other organism’s attributes
These bizarre mollusks have the ability to regenerate their bodies and to absorb other organisms’ attributes.
AI-discovered drug for ALS enters human trials in just four years
Verge Genomics has begun a trial of their AI-found ALS drug candidate, one of the first tests for this new method of drug discovery.
Understanding cancer’s “dark matter”
Researchers have discovered that cancer’s epigenome — changes to how genes are expressed that aren’t mutations — may play a key role in its behavior.
FDA approves first-of-its-kind blood cancer treatment
The FDA has approved Johnson & Johnson’s Tecvayli, a new blood cancer treatment for people with relapsed or refractory multiple myeloma.
What you eat can reprogram your genes
You are what you eat, and what your parents ate, and what their parents ate. An expert explains how the foods you eat can reprogram your genes.
Australian researchers have manufactured a living blood vessel
A blood vessel isn’t just a simple tube. Researchers at the University of Sydney have developed an implant capable of mimicking its complexities.
To avoid the worst effects of aging, we might need to exercise harder than we thought
To avoid one of the worst side effects of aging—bone, joint, and muscle pain—we might need to exercise a lot harder and more often.
New VR body suit lets you see inside your body while you exercise
A system for monitoring motion and muscle engagement could aid the elderly and athletes during physical rehabilitation.
Flu and RSV can fuse into a new kind of virus
In a new discovery, researchers at the University of Glasgow have observed hybrid viruses capable of infecting lung cells in the lab.
New smart contact lens monitors for glaucoma 24/7
Purdue researchers have created a smart, soft contact lens that can test for eye pressure, a key indicator of glaucoma, 24 hours a day.
Subscribe to the newsletter